The Role of Body Mass Index in Triple Negative Breast Cancer

Publisher： Karger

E-ISSN： 2296-5262|38|10|518-522

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.38, Iss.10, 2015-0, pp. : 518-522

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of the androgen receptor in triple-negative breast cancer

By Shah Payal D   Gucalp Ayca   Traina Tiffany A  

Women's Health, Vol. 9, Iss. 4, 2013-07 ,pp. : 351-360

Future Medicine

Access to resources Recommend Favorite

Height, body mass index (BMI), BMI change, and the risk of estrogen receptor‐positive, HER2‐positive, and triple‐negative breast cancer among women ages 20 to 44 years

By  

CANCER, Vol. 120, Iss. 10, 2014-05 ,pp. : 1548-1556

John Wiley & Sons Inc

Access to resources Recommend Favorite

Triple-negative breast cancer

By Bartsch Rupert  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 7-8, 2010-04 ,pp. : 174-181

Springer Publishing Company

Access to resources Recommend Favorite

Role of Carboplatin in the Treatment of Triple Negative Early- Stage Breast Cancer

By  

Reviews on Recent Clinical Trials, Vol. 10, Iss. 2, 2015-01 ,pp. : 101-110

Bentham Science Publishers

Access to resources Recommend Favorite

Triple Negative Breast Cancer: A Review

By  

Current Women's Health Reviews, Vol. 5, Iss. 3, 2009-01 ,pp. : 149-156

Bentham Science Publishers

Access to resources Recommend Favorite